InVivoMAb Anti-EBV/HHV4 gB/BALF4 Antibody (Iv0134)

Description: InVivoMAb Anti-EBV/HHV4 gB/BALF4 Antibody (Iv0134) [Iv0134] (RA11798) is a human monoclonal antibody detecting Envelope glycoprotein B in Neutralization, FCM, WB, IHC, ELISA.
Highlights:
• Multi-Application — Validated across multiple applications.
• Flow Cytometry — Validated for flow cytometry applications.
Host species: Human
Isotype: IgG1, kappa
Species reactivity: Epstein-Barr virus (strain GD1) (HHV-4) (Human herpesvirus 4)
Form: Liquid
Storage buffer: 0.01M PBS, pH 7.4.
Concentration: 1.35 mg/ml
Purity: >95% as determined by SDS-PAGE.
Clonality: Monoclonal
Applications: Neutralization
Target: Envelope glycoprotein B, gB, BALF4, gB, EBVaGC1_061
Purification: Protein A/G purified from cell culture supernatant.
Endotoxin level: Please contact with the lab for this information.
Stability and Storage: Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at 4°C short term (1-2 weeks). Store at -20°C 12 months. Store at -80°C long term.
Alternative Names:
Background: Envelope glycoprotein B (gB/BALF4) is a ~95 kDa protein. Envelope glycoprotein that forms spikes at the surface of virion envelope. Essential for the initial attachment to heparan sulfate moieties of the host cell surface proteoglycans. Involved in fusion of viral and cellular membranes leading to virus entry into the host cell. Following initial binding to its host receptors, membrane fusion is mediated by the fusion machinery composed at least of gB and the heterodimer gH/gL. May be involved in the fusion between the virion envelope and the outer nuclear membrane during virion egress.
Note: For research use only. Not suitable for clinical or therapeutic use.